Book Chapters and Reviews
Displaying 102 Publications
102
First Reported SPECT/CT to investigate pharmacokinetics of host defence peptides.
Saatchi K., T.V.F. Esposito, D. Pletzer, C. Blackadar, C. Rodriguez-Rodriguez, R.E.W. Hancock, and U.O. Hafeli.
(2019),
In Europ. J. Nuclear Med. Molec. Imaging.
46:
S433-S434
101
The critical need for alternative approaches to address antibiotic treatment failure.
Hancock, R.E.W.
(2020),
Revive:
GARDP
100
Is synergy the key to treating high-density infections?
Pletzer D, Hancock, R.E.W.
(2018), Future Microbiol.
13:
1629-1632
99
Impact of Host Defense Peptides on Chronic Wounds and Infections
Haney EF, D Pletzer, R.E.W. Hancock
(2018),
In Recent Clinical Techniques, Results, and Research in Wounds
1-17 Springer, Cham
98
Host defense (antimicrobial) peptides
Sun E, CR Belanger, EF Haney, REW Hancock
(2017),
In Peptide Applications in Biomedicine, Biotechnology and Bioengineering
253-286 (Sotirios Koutsopoulos , eds.) Woodhead Publishing
PDF
97
33 CFTR modulators alter innate immune responses by primary airway epithelial cells challenged with rhinovirus
L Garratt, K Looi, K-M Ling, KM Martinovich, R Falsafi, T Iosifidis, NC Shaw, ST Montgomery, E Kicic-Starcevich, EN Sutanto, A Kicic, REW Hancock, SM Stick
(2017), J Cyst Fibros
16:
S71-S72
PDF
96
Immunomodulatory Activities of Cationic Host Defence Peptides and Novel Therapeutic Strategies
Wuerth KC, Hancock REW
(2017),
In Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies
2:
238-260 (Guangshun Wang , eds.) CABI
95
Antibiotic resistance due to reduced uptake.
Fernandez, L. J.B. McPhee, S. Tamber, S. Lewenza, M.D. Brazas, and R.E.W. Hancock.
(2017),
In Antimicrobial drug resistance: Principles and practice for the clinical bench.
115-130 (D.L. Mayers, J.D. Sobel, M. Ouellette, K.S. Kaye, and D. Marchaimed, , eds.) Humana Press, New Jersey.
94
93
An alternative approach to treating antibiotic-resistant infections
Trimble, M.J., and R.E.W. Hancock
(2017),
In Future Microbiology
12:
201-204 Future Medicine Ltd
92
Host Defense Peptides and Their Advancements in Translational Staphylococcus aureus Research.
Mansour S.C., R.E.W. Hancock, M. Otto
(2016),
In Host Defense Peptides and Their Potential as Therapeutic Agents.
1:
301-321 (Epand R.M. , eds.) Springer International Publishing.
PDF
91
Polymyxin: alternative mechanisms of action and resistance.
Trimble, M.J., P. Mlynarcik, M. Kolar, and R.E.W. Hancock.
(2016),
In Cold Spring Harbor Perspectives in Medicine:
3;6(10):
90
Bioinformatics: Novel Insights from Genomic Information.
Hancock, R.E.W.
(2016),
In Next-Generation Nutritional Biomarkers to Guide Better Health Care.
84:
35-46 (Baetge E.E., Dhawan A., Prentice A.M. , eds.) Karger Publishers.
89
88
Electrophoresis and Blotting of DNA.
Sedivy-Haley, K., S. Tamber, and R.E.W. Hancock
(2013),
In eLS 2013
John Wiley & Sons, Chichester
87
86
Host defense peptides: Immune modulation and antimicrobial activity in vivo.
Afacan, N.J., L.M. Janot, and R.E.W. Hancock.
(2013),
In Antimicrobial peptides and innate immunity, Progress in Inflammation Research
321-358 (P.S. Hiemstra and S.A.J. Zaat , eds.) Springer Basel.
PDF
85
Host Defence (Antimicrobial) Peptides and Proteins.
Wuerth, Kelli C; Hilchie, Ashley L; Brown, Kelly L; and Hancock, REW
(2013),
In eLS 2013
77-84 John Wiley & Sons Ltd: Chichester
84
Cathelicidins.
Mookerhjee, N., K.L. Brown and R.E.W.Hancock.
(2013),
In Handbook of Biologically Active Peptides
Ch. 15 (Kastan, A. ed.; Hancock, R.E.W. section ed , eds.) Elsevier
83
Immunomodulatory cationic peptide therapeutics: A new paradigm in infection and immunity.
Mookherjee, N., L. Chow and R.E.W. Hancock.
(2012),
In Small Wonders: Peptides for Disease Control.
Ch. 1, pp. 1-19 (K. Rajasekaran, J.W. Cary, J.M. Jaynes, & E. Montesinos , eds.) ACS Books.
PDF
82
Pseudomonas aeruginosa: a persistent pathogen in cystic fibrosis and hospital-associated infections.
Schurek, K.N., E.B.M. Breidenstein and R.E.W. Hancock.
(2012),
In Antibiotic Drug Discovery and Development
679-715 (T.J. Dougherty and M.J. Pucci , eds.) Springer Publishing Company.
PDF
81
Importance of adaptive and stepwise changes in the rise and spread of antimicrobial resistance.
Fernández, L., E.B.M. Breidenstein, and R.E.W. Hancock.
(2011),
In Antimicrobial resistance in the environment.
43-71 (Keen P., Monforts M. , eds.) John Wiley and Sons.
PDF
80
Host Defense Peptides.
Pena, O.M., J.D.F. Hale, and R.E.W. Hancock.
(2011),
In Emerging Trends in Antibacterial Discovery – Answering the Call to Arms
Ch 15. pp. 323-344. (AA. Miller and P.F. Miller , eds.) Calister Academic Press, Norfolk, UK.
79
Host defence (Antimicrobial) Peptides and Proteins.
Madera, L., S. Ma, and R.E.W. Hancock.
(2010),
In The Immune response to infection.
57-68. (Kaufmann, S.H.E., B. Rouse, and D. Sacks , eds.) ASM Press, Wasshington, DC.
78
Fine tuning host responses in the face of infection: Emerging roles and clinical applications of host defence peptides.
Mayer M.L., D.M. Easton, and R.E.W. Hancock.
(2010),
In Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies.
Chapter 12, pp. 195-220 (G. Wang , eds.) CABI: Oxfordshire, UK.
77
Introduction to the Theme: Seeking Clarity for Membrane-active Peptides.
Hancock, R.E.W.
(2010),
In Membrane-active peptides: Methods and Results on Structure and Function.
3-9 (M. Castanho, , eds.) International University Line, La Jolla.
76
Systems-Level Analyses of the Mammalian Innate Immune Response.
Lynn D.J., J.L. Gardy, C.D. Fjell, R.E.W. Hancock, and F.S.L.Brinkman 2010
(2010),
In Systems Biology for Signaling Networks
1 part 3:
531-560 Springer Publishing, N.Y.
PDF
75
Host defense peptides: Bridging antimicrobial and immunomodulatory activities
Kindrachuk, J., A. Nijnik, and R.E.W. Hancock.
(2010),
In Comprehensive Natural Products II Chemistry and Biology
5:
175-216 (Mander, L., Lui, H.-W , eds.) Elsevier: Oxford
74
Host Defense Peptides in Fish: From the Peculiar to the Mainstream, in Fish Defenses
Patrzykat, A., and R.E.W. Hancock
(2009),
In Pathogens, Parasites and Predators
Vol 2.:
43-63 (G. Zaccone, C. Perrière, A. Mathis, and B.G. Kapoor , eds.) Science Publishers, New Hampshire.
73
Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides.
Jiang Z., A.I. Vasil, J. Hale, R.E.W. Hancock, M.L. Vasil, and R.S. Hodges.
(2009),
In Adv. Exp. Med. Biol.
611:
561-562
PDF
72
Synthesis of peptide arrays using SPOT-technology and the CelluSpots-method.
Winkler, D.F.H., K. Hilpert, O. Brandt and R.E.W. Hancock
(2009),
In Peptide Microarrays.
Humana Press, New Jersey,
PDF
71
Antibiotic resistance due to reduced uptake.
McPhee, J.B., S. Tamber, S. Lewenza, M.D. Brazas, and R.E.W. Hancock.
(2009),
In Antimicrobial drug resistance: Principles and practice for the clinical bench
97-110 (D.L. Mayers, , eds.) Humana Press, New Jersey.
PDF
70
Antibacterial host defence peptides of bovine origin.
Jenssen H., K.Hilpert, and R.E.W. Hancock.
(2007),
In Chem. Today.
25:
17-19
69
Immunomodulatory properties of defensins and cathelicidins.
Bowdish, D.M.E., D.J. Davidson, and R.E.W. Hancock.
(2006),
In Curr. Top. Microbiol. Immunol.
306:
24-66
PDF
68
Cathelicidins: Cationic Host Defense and Antimicrobial Peptides.
Mookerhjee, N., K.L. Brown and R.E.W.Hancock.
(2005),
In Handbook of Biologically Active Peptides
55-66 (Kastan, A. ed.; Hancock, R.E.W. section ed , eds.)
67
Using the Pseudomonas aeruginosa genome to understand pathogenesis.
Hancock, R.E.W.
(2004),
In Ped. Pulmon.
S27:142-143.
66
Porins of the outer membrane of Pseudomonas aeruginosa.
Hancock, R.E.W., and S. Tamber.
(2004),
In Bacterial and Eukaryotic Porins.
Ch. 4, pp. 61-77 (Benz, R., , eds.) Wiley VCH Verlag, Weinheim.
PDF
65
Bacterial Structure and Physiology: Influence on Susceptibility to Cationic Antimicrobial Peptides.
Hancock, R.E.W.
(2004),
In Mammalian host defence peptides
226-244 (D.A. Devine and Hancock, R.E.W., , eds.) Cambridge University Press, NY.
PDF
64
“Antimicrobial” or “host defence” peptides?
Hancock, R.E.W., and D.A. Devine.
(2004),
In Mammalian host defence peptides.
1-4 (D.A. Devine and Hancock, R.E.W , eds.) Cambridge University Press, NY.
PDF
63
Mammalian host defence peptides.
Hancock, R.E.W., and D.A. Devine,
(2004),
In Advances in Molecular and Cellular Microbiology Series.
Cambridge University Press, NY.
PDF
62
The Outer Membranes of Pseudomonads.
Tamber, S., and R.E.W. Hancock.
(2004),
In The Pseudomonads
Vol I:
575-601 (J.L. Ramos, , eds.) Kluwer Academic, NY.
PDF
61
Bacterial biofilms of importance to medicine and bioterrorism: proteomic techniques to identify novel vaccine components and drug target.
Hassett, D.J., P.A. Limbach, R.F. Hennigan, K.E, Klose, R.E.W. Hancock, M.D.Platt, D.F. Hunt.
(2003),
In Exp. Opin. Biol. Ther.
3:
1201-1207
PDF
60
Electrophoresis and blotting of DNA
Tamber, S., and R.E.W. Hancock.
(2003),
In Nature Encyclopaedia of Life Sciences.
London
59
Cationic peptides: Distribution and mechanisms of resistance.
Devine, D.A., and R.E.W.Hancock.
(2002),
In Curr. Pharmaceut. Design
8:
99-110
58
Cationic anti-microbial peptides.
Hancock, R.E.W.
(2002),
In Biochem. Cell Biol.
80:
140
57
56
Antimicrobial peptides for fish disease control.
Hancock, R.E.W., and A. Patrzykat.
(2001),
In Recent advances in marine biotechnology Vol. 7: Seafood Safety and Human Health
Oxford and IBH Publishing Co., New Delhi.
55
Mechanism of action of imipenem and relevance of porin OprD.
Hancock, R.E.W.
(2001),
In Infections in Oncology
5:
2-3
54
Cationic antimicrobial peptide antibiotics.
Hancock, R.E.W., and P.Nair.
(2000),
In Curr. Opin. Antiinfective Invest. Drugs.
2:
140-148
53
Antibiotic resistance and survival in the host.
Macfarlane, E.L.A., and R.E.W. Hancock.
(2000),
In Virulence mechanisms of bacterial pathogens
3rd Edition:
93-104 (Brogden, K., J.A. Roth, T.B. Stanton, C.A. Bolin, F.C. Minion, and M.J. Wannemuehler, , eds.) ASM Press, Washington, DC.
52
Insect cationic antimicrobial peptides.
Hetru, C., J.A.Hoffmann, and R.E.W.Hancock.
(2000),
In Peptide antibiotics: Discovery, modes of action and applications.
(Dutton, C., M.Haxell, H.I. McArthur, and R.Wax. Peptide , eds.) Marcel Dekker, New York.
51
Peptide antibiotics.
Zhang, L., and R.E.W.Hancock.
(2000),
In Antibiotic resistance and antibiotic development.
209-232 (Hughes, D., and Andersson, D.I., , eds.) Harwood Academic Publishers.
50
Cationic peptide antibiotics for use in treatment of Pseudomonas aeruginosa infections of cystic fibrosis patients.
Hancock, R.E.W., M. Scott, C.Friedrich, L.Zhang, H.Yan, P.Nair, A.Patrzykat, and A.Rozek.
(1999),
In Clin. Microbiol. Infect
5:
S52-S53.
PDF
49
Cationic peptide antibiotics: a diversified portfolio for the future.
48
47
Anti-microbial activities of phytochemicals from British Columbian medicinal plants.
Towers, G.H.N., McCutcheon, A., Saxena, G., Matsuura, H., Page, J., Farmers, S., Gibbons, E. Roberts, T.E., Babiuk, L.A., Thorson, I.M., Stokes, R.W., Sokol, P., Klingemann, H., and Hancock, R.E.W.
(1999),
In Chemistry, Biological, and Pharmacological Properties of Medicinal Plants from the Americas.
125-142 (Hostettmann, K., Gupta, M.P., and Marston, A. , eds.) Harwood Academic Publ. Switzerland.
46
Are we approaching the end of the antibiotic era? Editorial overview.
45
Pseudomonas aeruginosa: Infection and Immunity.
Hancock, R.E.W. and J.S. Lam
(1998),
In Encyclopaedia of Immunology
2nd Edition 4:
2042-2045 (P.J.Delves , eds.) Academic Press, London.
PDF
44
Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria.
43
Outer membrane proteins
Hancock, R.E.W., and E.A. Worobec.
(1998),
In Biotechnology Handbooks.
10 Pseudomonas, :
139-167 (Montie T., , eds.) Plenum Press, London.
PDF
42
41
Potential of protein OprF of Pseudomonas in bivalent vaccines.
Hancock, R.E.W. and R. Wong.
(1997),
In Behring Institute Mitteilungen
98:
283-290 (Domdey, H., W. Lubitz, F. Schodel and B. von Specht , eds.) DMV, Marburg.
PDF
40
Isolation and characterization of porins from H. pylori.
Hancock, R.E.W. and M. Exner.
(1997),
In Methods Molec. Med. Helicobacter pylori protocols.
191-204 (Clayton, C.L. and H.L.T. Mobley , eds.) Humana Press In., Totowa, N.J.
PDF
39
Antibiotics for Pseudomonas and related infections.
Hancock, R.E.W., and D.P. Speert.
(1996),
In Cystic Fibrosis - current topics (
3:
245-266 (Dodge, J.A., Brock, D.J.H., and Widdicombe, J.H., , eds.) John Wiley and Sons Ltd.
PDF
38
Cationic peptides: a class of antibiotics able to access the self promoted uptake pathway across the outer membrane of Pseudomonas aeruginosa.
Hancock, R.E.W., K. Piers, M. Brown, T. Falla, M. Gough, M. Wu and S. Fidai.
(1996),
In Molecular Biology of Pseudomonads.
(Nakazawa, T., Furukawa, K., Haas, D., and Silver, S., , eds.) ASM Press, Washington.
PDF
37
Cationic Peptides
Hancock, R.E.W., and T. Falla,
(1996),
In Biotechnology of Antibiotics
2:
Ch 16. 467-492 (Strohl, W.R., , eds.) Marcell Dekker Inc., N.Y.
PDF
36
Small Peptide Antibiotics.
Hancock, R.E.W., S. Fidai, M. Gough, M. Wu, and K. Piers.
(1994),
In Pediatric Pulmonology
10(S):
161-162
PDF
35
Bacterial transport as an import mechanism and target for antimicrobials.
Hancock, R.E.W.
(1994),
In Drug transport in antimicrobial and anticancer chemotherapy
293-306 (Georgopapadakou, N. , eds.) Marcel Dekker, Inc., New York.
PDF
34
Cationic Bactericidal peptides
33
32
Cloning of outer membrane protein genes and molecular genetic methods for studying structure function relationships.
Siehnel, R.J., R.S.Y. Wong, H. Huang and R.E.W. Hancock
(1994),
In Meth. Molec. Genet.
3:
311-324
PDF
31
Outer membrane proteins.
Hancock, R.E.W., and K. Piers.
(1994),
In Escherichia coli in animals.
495-532 (Gyles C.L , eds.) International, Wallingford, U.K.
PDF
30
Molecular organization and structural role of outer membrane macromolecules.
Hancock, R.E.W., C. Egli and N. Karunaratne.
(1994),
In Bacterial Cell Envelope
263-279 (J.M. Ghuysen and Hakenbeck, R., , eds.) Elsevier Science Publishers BV, Amsterdam.
PDF
29
Susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents.
Bellido, F., and R.E.W.Hancock.
(1994),
In Pseudomonas aeruginosa as an opportunistic pathogen.
321-348 (Campa, M., M. Bendinelli, and H.Friedman, , eds.) Plenum Press, NY.
PDF
28
Bacterial Porins.
27
Function and structure of Pseudomonas aeruginosa outer membrane protein OprF.
Bellido, F., R.L. Finnen, N.L. Martin, R.J. Siehnel and R.E.W. Hancock.
(1992),
In Pseudomonas: Molecular Biology and Biotechnology.
170-176 (Galli, E., S. Silver and B. Witholt , eds.) American Society for Microbiology, Washington, D.C.
PDF
26
Bacterial outer membranes: Evolving Concepts.
25
LPS integration into outer membrane structures.
Hancock, R.E.W. and N. Karunaratne.
(1990),
In Cellular and Molecular Aspects of Endotoxin Reactions.
I:
191-196 (Nowotny, A., Spitzer, J.J., and Ziegler, E.J., , eds.) Elsevier Science Publishers B.V., Amsterdam.
PDF
24
Function and structure of the porin proteins OprF and OprP of Pseudomonas aeruginosa.
Siehnel, R.J., N.L. Martin and R.E.W. Hancock.
(1990),
In Pseudomonas: Biotransformations, pathogenesis and evolving biotechnology.
328-342 (Silver, S., A.M. Chakrabarty, B. Iglewski, and S. Kaplan , eds.) American Society for Microbiology, Washington.
PDF
23
Function and structure of the major components of the outer membrane of gram-negative bacteria.
Martin, N.L. and R.E.W. Hancock.
(1990),
In Advances in Brucellosis Research
55-75 (L.G. Adams , eds.) Texas A & M University Press, College Station.
PDF
22
Antibiotic uptake into Gram negative bacteria.
Hancock, R.E.W. and A. Bell.
(1989),
In Perspectives in anti-infective therapy
21-28 (G.G. Jackson, H.D. Schlumberger, and H.J. Zeiler, , eds.) Vieweg and Sohn, Braungshweig.
PDF
21
20
Role of outer membrane components in Pseudomonas aeruginosa colonization of the cystic fibrosis lung.
19
Antibiotic uptake pathways across the outer membrane of Pseudomonas aeruginosa.
Moore, R.A., W.A. Woodruff and R.E.W. Hancock.
(1987),
In . Antibiotics and Chemotherapy
39:
172-181
PDF
18
Phosphate-binding site of Pseudomonas aeruginosa outer membrane protein P.
Hancock, R.E.W., E.A. Worobec, K. Poole and R. Benz.
(1987),
In Phosphate metabolism and cellular regulation in microorganisms
176-180 (Torriani, A., Silver, S., Rathman, F., Wright, A., and Yagel, E., , eds.) ASM, Washington.
PDF
17
Model membrane studies of porin function.
Hancock, R.E.W.
(1987),
In Bacterial Outer Membranes as Model Systems
187-226 (Inouye, M., , eds.) John Wiley and Sons, New York.
PDF
16
The penetration of antibiotics into the antibiotic resistant bacterium seudomonas aeruginosa: Interaction of polycationic antibiotics at a common site on the lipopolysaccharide.
15
The outer membrane proteins of Pseudomonas aeruginosa: Immunotherapeutic potential.
Hancock, R.E.W., E.C.A. Mouat, S.L. Butters and D.P. Speert.
(1986),
In Seminars in Infectious Diseases.
(Robbins, J.B., , eds.)
PDF
14
Outer membrane permeability of Pseudomonas aeruginosa.
Nikaido, H. and R.E.W. Hancock
(1986),
In The Bacteria: A treatise on structure and function.
X:
145-193 (Sokatch, J.R., , eds.) Academic Press, London.
PDF
13
Monoclonal Antibodies against bacterial outer membrane antigens.
Hancock, R.E.W. and L.M. Mutharia.
(1985),
In Advances in Experimental Medicine and Biology
185:
215-222 (Atassi, M. and H.L. Bachrach , eds.) Plenum Press Inc., New York.
PDF
12
The Pseudomonas aeruginosa outer membrane permeability barrier and how to overcome it.
Hancock, R.E.W.
(1985),
In Antibiotics and Chemotherapy
95-102 (Speert, D.P., and R.E.W. Hancock , eds.) S. Karger, Basel.
PDF
11
Laboratory characterization of lipopolysaccharides (LPS).
Hancock, R.E.W.
(1985),
In Bayer Symposium VII: Pathogenesis of Bacterial Infections.
398 (G.G. Jackson and J. Thomas, , eds.) Springer-Verlag, Berlin.
PDF
10
Monoclonal antibody protection against Pseudomonas aeruginosa.
Hancock, R.E.W.
(1985),
In Bayer Symposium VII: Pathogenesis of Bacterial Infections.
422-424 (G.G. Jackson and J. Thomas, , eds.) Springer-Verlag, Berlin.
PDF
9
The role of the cell surface components of Pseudomonas aeruginosa in virulence.
Hancock, R.E.W.
(1985),
In Bayer Symposium VII: Pathogenesis of Bacterial Infections.
247-256 (G.G. Jackson and J. Thomas, , eds.) Springer-Verlag, Berlin.
PDF
8
Application of monoclonal antibodies to the study of the surface antigens in Pseudomonas aeruginosa.
Lam, J.S.L., L.M. Mutharia and R.E.W. Hancock.
(1985),
In Monoclonal antibodies against bacteria
II:
143-157 (A.J.L. Macario and E.C. Macario, , eds.) Academic Press, New York.
PDF
7
Use of monoclonal antibodies in the study of common antigens in gram negative bacteria.
Mutharia, L.M., J.S.L. Lam and R.E.W. Hancock.
(1985),
In Monoclonal antibodies against bacteria
131-142 (A.J.L. Macario and E.C. de Macario, , eds.) Academic Press, New York.
PDF
6
Ionic channels in membranes.
Benz, R., K. Poole and R.E.W. Hancock.
(1984),
In Biophysical Discussions
81-82 (Parsegian, V.A., , eds.) Rockefeller University Press, New York.
PDF
5
Resistance to antibacterial agents acting on cell membranes.
Hancock, R.E.W. and T.I. Nicas.
(1984),
In Antimicrobial Drug Resistance
147-171 (Bryan, L.E., , eds.) Academic Press, New York.
PDF
4
Molecular Interactions of aminoglycosides with bacteria - Implications for therapy.
Hancock, R.E.W., B. Loh and T.I. Nicas.
(1983), Proc. 13th International Congress of Chemotherapy
35:
1-3
3
Porins from gram-negative bacteria in lipid bilayer membranes
Benz R., R.E.W. Hancock, T. Nakae
(1982),
In Transport in Biomembranes: Model systems and reconstitution
123-134 (Antolini et al , eds.) Raven Press, New York
PDF
2
Functional organization of the outer membrane of Escherichia coli: Phage and colicin receptors as components of iron uptake systems.
Braun, V., R.E.W. Hancock, K. Hantke and A. Hartman.
(1976),
In Progress in Clinical and Biological Research
17:
11-32 (Revel, J.P., U. Henning and C.F. Fox , eds.) Alan R. Liss Inc., New York.
PDF
1
A mutation in Escherichia coli K-12 affecting conjugation, phage resistance and a major membrane protein
Hancock, R.E.W., R.A. Skurray and P. Reeves.
(1975), Proc. Aust. Biochem. Soc.
7:
80